TRDA filings
Corporate insider profile
Ansbert Gadicke Filing Activity
Latest reported as Corporate insider of Entrada Therapeutics, Inc. (TRDA).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$3,600,472.86
- Latest transaction
- Sep 9, 2026
Affiliated corporations
Reported company relationships
Transaction history